Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
62 hedge funds and large institutions have $45M invested in Marrone Bio Innovations, Inc. in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 18 reducing their positions, and 22 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less capital invested
Capital invested by funds: $46.4M → $45M (-$1.43M)
13% less funds holding
Funds holding: 71 → 62 (-9)
33% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 18
36% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GLAM
Gardner Lewis Asset Management
Chadds Ford,
Pennsylvania
|
+$1.35M |
| 2 |
Millennium Management
New York
|
+$1.29M |
| 3 |
OFA
Oak Family Advisors
Chicago,
Illinois
|
+$518K |
| 4 |
E
Ergoteles
New York
|
+$475K |
| 5 |
EFI
EHP Funds Inc
Toronto,
Canada
|
+$319K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$4.55M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$728K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$726K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$651K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$566K |
MBII Hedge Fund Activity: Q2 2022 in Review
62 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q2 2022, worth a combined $45M — down 3.1% from $46.4M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of MBII and 14 opened new positions — a net loss of 8 holders — while 18 trimmed existing stakes and 12 added.
The largest buyer was Gardner Lewis Asset Management, adding an estimated $1.35M. The largest seller was BlackRock, cutting an estimated $4.55M.
- 62 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q2 2022, down from 71 in Q1 2022.
- Funds reported $45M of Marrone Bio Innovations, Inc. stock for Q2 2022, down 3.1% quarter-over-quarter.
- 14 funds opened new Marrone Bio Innovations, Inc. positions in Q2 2022 and 22 closed out, a net change of -8 holders.
- The largest Marrone Bio Innovations, Inc. buyer in Q2 2022 was Gardner Lewis Asset Management, an estimated $1.35M added.
- The largest Marrone Bio Innovations, Inc. seller in Q2 2022 was BlackRock, an estimated $4.55M sold.
Based on aggregated 13F filings for Q2 2022.